Ryan Specialty Group (RYAN) Tops Q2 EPS by 4c

Ryan Specialty Group (NYSE: RYAN) reported Q2 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $491.3 million versus the consensus estimate of $459.81 million.

Full Year 2022 Outlook:

The Company is raising its full year 2022 outlook for both Organic revenue growth rate and Adjusted EBITDAC margin as follows:

• Organic revenue growth rate guidance range for the full year 2022 is now 16.5% – 18.0%, compared to the Company’s prior guidance range of 13.5% - 15.5%.
• Adjusted EBITDAC margin guidance range for the full year 2022 is now 29.0% - 30.0%, compared to the Company’s prior guidance range of 28.5% - 30.0%.

For earnings history and earnings-related data on Ryan Specialty Group (RYAN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c